Relay Therapeutics Inc Cash Flow Quality Index
Latest as of December 2020:
-1.00x
Relay Therapeutics Inc cash flow quality index. Relay Therapeutics Inc (RLAY) has a Cash Flow Quality Index of -1.00x as of December 2020. Operating cash flow of $-35.27 Million is below net income of $35.28 Million, suggesting accrual-heavy earnings not yet converted to cash. See RLAY financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
-1.00x
Operating CF / Net Income
Operating Cash Flow
$-35.27 Million
USD
Net Income
$35.28 Million
USD
Data as of
Dec 2020
Most recent filing
Relay Therapeutics Inc Cash Flow Quality Index by Year (None–None)
Relay Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Relay Therapeutics Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Relay Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.